BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 3, 2000
View Archived Issues
Research links autoantibodies to the symptoms of Sjogren's syndrome
Read More
New findings on an old drug: metformin
Read More
Possible connection between intestinal bacteria and autism revealed
Read More
Amiloride fails to show benefit in cystic fibrosis trial
Read More
Magainin receives patent for novel obesity compound
Read More
New technology may improve safety in testing of adenovirus-based gene therapies
Read More
Licensing opportunity from NIH: methods of gene targeting
Read More
Adeno-associated virus vector available for licensing from NIH
Read More
Licensing opportunity from NIH: AAV4 and its use for gene delivery
Read More
NIH offers apoptosis-inducing gene product for licensing
Read More
Licensing opportunity from NIH: replication-deficient retroviral vectors
Read More
Overexpression of UCP-3 results in reduced tissue mass in mice
Read More
Inconclusive results obtained with desferrioxamine in multiple sclerosis trial
Read More
Roche seeks approval of Tamiflu in Japan
Read More
Bayer's Cipro recommended for approval in treating anthrax exposure
Read More
Acadia granted phase I SBIR award for neuropsychiatric research
Read More
Concerta approved by FDA, licensed worldwide by Alza
Read More
Bavarian Nordic initiates phase I/II trial of metastatic malignant melanoma treatment
Read More
New compounds under development at AHP for treatment of inflammatory and autoimmune diseases
Read More
JNK protein kinase inhibitors under study at Roche
Read More
New selective dopamine D4 receptor antagonists useful for psychosis and schizophrenia
Read More
Antibacterial agents under development at British Biotech
Read More
New compounds interacting with 5-HT1A receptors useful for depression, etc.
Read More
New polypeptides useful for Chlamydia infection
Read More
New human lymphocytic membrane proteins under study at Incyte
Read More